U.S. And Europe Lateral Flow Assay Market (2025 - 2030) Size, Share & Trends Analysis Report Product (Kits & Reagents, Lateral Flow Readers), By Application, By Technique, By Test Type, By End Use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Information or Data Analysis
                        1.3.3. Market Formulation & Data Visualization
                        1.3.4. Data Validation & Publishing
                    1.4. Research Scope and Assumptions
                        1.4.1. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. And Europe Lateral Flow Assay Market Variables, Trends, & Scope
                    3.1. Market Introduction/Lineage Outlook
                    3.2. Market Size and Growth Prospects (USD Million)
                    3.3. Market Dynamics
                        3.3.1. Market Drivers Analysis
                            3.3.1.1. Increasing prevalence of infectious diseases
                            3.3.1.2. Technological advancements in lateral flow
                            3.3.1.3. Growing adoption in homecare settings
                        3.3.2. Market Restraints Analysis
                            3.3.2.1. Stringent Regulations
                        3.3.3. Market Opportunities Analysis
                            3.3.3.1. Growing demand for Point-of-Care (POC) Testing
                            3.3.3.2. Expanding applications beyond healthcare
                        3.3.4. Market Challenges Analysis
                            3.3.4.1. Product Recalls
                    3.4. U.S. and Europe Lateral Flow Assay Market Analysis Tools
                        3.4.1. Porter’s Analysis
                            3.4.1.1. Bargaining power of the suppliers
                            3.4.1.2. Bargaining power of the buyers
                            3.4.1.3. Threats of substitution
                            3.4.1.4. Threats from new entrants
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Economic and Social landscape
                            3.4.2.3. Technological landscape
                            3.4.2.4. Environmental landscape
                            3.4.2.5. Legal landscape
Chapter 4. U.S. And Europe Lateral Flow Assay Market: Product Estimates & Trend Analysis
                    4.1. U.S. and Europe Lateral Flow Assay Market: Product Movement Analysis
                    4.2. U.S. and Europe Lateral Flow Assay Market Estimates and Forecasts, by Product 2024 & 2030 (USD Million)
                    4.3. Kits & Reagents
                        4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.4. Lateral Flow Readers
                        4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.2. Benchtop Readers
                            4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.4.3. Digital Readers
                            4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. And Europe Lateral Flow Assay Market: Application Estimates & Trend Analysis
                    5.1. U.S. and Europe Lateral Flow Assay Market: Application Movement Analysis
                    5.2. U.S. and Europe Lateral Flow Assay Market Estimates and Forecasts, by Application 2024 & 2030 (USD Million)
                    5.3. Clinical Testing
                        5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.2. Infectious Disease Testing
                            5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.2. COVID-19
                                5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.3. Mosquito Borne Disease Testing
                                5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.4. Influenza Testing
                                5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.5. Sexually Transmitted Infection Testing
                                5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.2. HIV Testing
                                    5.3.2.5.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.3. HPV Testing
                                    5.3.2.5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.4. Chlamydia Testing
                                    5.3.2.5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.5. Gonorrhea Testing
                                    5.3.2.5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.6. Syphilis Testing
                                    5.3.2.5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                                5.3.2.5.7. Other STI Testing
                                    5.3.2.5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.6. Hepatitis
                                5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.7. Tuberculosis
                                5.3.2.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.2.8. Other Infectious Diseases
                                5.3.2.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.3. Cardiac Marker Testing
                            5.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.2. Troponin I and T Testing
                                5.3.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.3. CK-MB Testing
                                5.3.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.4. BNP and NT-Probnp Testing
                                5.3.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.5. Myoglobin Testing
                                5.3.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.6. D-Dimer Testing
                                5.3.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.3.7. Other Cardiac Marker Tests
                                5.3.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.4. Pregnancy & Fertility Testing
                            5.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.4.2. Pregnancy Testing
                                5.3.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                            5.3.4.3. Fertility Testing
                                5.3.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.5. Cholesterol Testing/Lipid Profile
                            5.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.6. Drugs of Abuse Testing
                            5.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.3.7. Other Clinical Tests
                            5.3.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.4. Veterinary Diagnostics
                        5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Food Safety & Environment Testing
                        5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Drug Development & Quality Testing
                        5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. And Europe Lateral Flow Assay Market: Technique Estimates & Trend Analysis
                    6.1. U.S. and Europe Lateral Flow Assay Market: Technique Movement Analysis
                    6.2. U.S. and Europe Lateral Flow Assay Market Estimates and Forecasts, by Technique 2024 & 2030 (USD Million)
                    6.3. Sandwich Assays
                        6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.4. Competitive Assays
                        6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Multiplex Detection Assays
                        6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. And Europe Lateral Flow Assay Market: Test Type Estimates & Trend Analysis
                    7.1. U.S. and Europe Lateral Flow Assay Market: Test Type Movement Analysis
                    7.2. U.S. and Europe Lateral Flow Assay Market Estimates and Forecasts, by Test Type 2024 & 2030 (USD Million)
                    7.3. Lateral Flow Immunoassay
                        7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.4. Nucleic Acid Lateral Flow Assay
                        7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. And Europe Lateral Flow Assay Market: End Use Estimates & Trend Analysis
                    8.1. U.S. and Europe Lateral Flow Assay Market: End-use Movement Analysis
                    8.2. U.S. and Europe Lateral Flow Assay Market Estimates and Forecasts, by End-use 2024 & 2030 (USD Million)
                    8.3. Hospitals & Clinics
                        8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.4. Diagnostic Laboratories
                        8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.5. Home Care
                        8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.6. Pharmaceutical & Biotechnology Companies
                        8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
                    8.7. Other End-use
                        8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. U.S. And Europe Lateral Flow Assay Market: Regional Estimates & Trend Analysis
                    9.1. U.S. and Europe Lateral Flow Assay Market Share, By Region, 2024 & 2030 (USD Million)
                    9.2. U.S.
                        9.2.1. Key Country Dynamics
                        9.2.2. Competitive Scenario
                        9.2.3. Regulatory Framework
                        9.2.4. Reimbursement Scenario
                        9.2.5. U.S. Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    9.3. Europe
                        9.3.1. Europe Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.2. UK
                            9.3.2.1. Key Country Dynamics
                            9.3.2.2. Competitive Scenario
                            9.3.2.3. Regulatory Framework
                            9.3.2.4. Reimbursement Scenario
                            9.3.2.5. UK Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.3. Germany
                            9.3.3.1. Key Country Dynamics
                            9.3.3.2. Competitive Scenario
                            9.3.3.3. Regulatory Framework
                            9.3.3.4. Reimbursement Scenario
                            9.3.3.5. Germany Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.4. France
                            9.3.4.1. Key Country Dynamics
                            9.3.4.2. Competitive Scenario
                            9.3.4.3. Regulatory Framework
                            9.3.4.4. Reimbursement Scenario
                            9.3.4.5. France Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.5. Italy
                            9.3.5.1. Key Country Dynamics
                            9.3.5.2. Competitive Scenario
                            9.3.5.3. Regulatory Framework
                            9.3.5.4. Reimbursement Scenario
                            9.3.5.5. Italy Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.6. Spain
                            9.3.6.1. Key Country Dynamics
                            9.3.6.2. Competitive Scenario
                            9.3.6.3. Regulatory Framework
                            9.3.6.4. Reimbursement Scenario
                            9.3.6.5. Spain Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.7. Denmark
                            9.3.7.1. Key Country Dynamics
                            9.3.7.2. Competitive Scenario
                            9.3.7.3. Regulatory Framework
                            9.3.7.4. Reimbursement Scenario
                            9.3.7.5. Denmark Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.8. Sweden
                            9.3.8.1. Key Country Dynamics
                            9.3.8.2. Competitive Scenario
                            9.3.8.3. Regulatory Framework
                            9.3.8.4. Reimbursement Scenario
                            9.3.8.5. Sweden Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        9.3.9. Norway
                            9.3.9.1. Key Country Dynamics
                            9.3.9.2. Competitive Scenario
                            9.3.9.3. Regulatory Framework
                            9.3.9.4. Reimbursement Scenario
                            9.3.9.5. Norway Lateral Flow Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Recent Developments & Impact Analysis by Key Market Participants
                    10.2. Company Categorization
                    10.3. Company Heat Map Analysis
                    10.4. Company Profiles
                        10.4.1. Abbott
                            10.4.1.1. Participant’s Overview
                            10.4.1.2. Financial Performance
                            10.4.1.3. Product Benchmarking
                            10.4.1.4. Recent Developments/ Strategic Initiatives
                        10.4.2. Bio-Rad Laboratories, Inc
                            10.4.2.1. Participant’s Overview
                            10.4.2.2. Financial Performance
                            10.4.2.3. Product Benchmarking
                            10.4.2.4. Recent Developments/ Strategic Initiatives
                        10.4.3. Siemens Healthineers AG
                            10.4.3.1. Participant’s Overview
                            10.4.3.2. Financial Performance
                            10.4.3.3. Product Benchmarking
                            10.4.3.4. Recent Developments/ Strategic Initiatives
                        10.4.4. BIOMÉRIEUX
                            10.4.4.1. Participant’s Overview
                            10.4.4.2. Financial Performance
                            10.4.4.3. Product Benchmarking
                            10.4.4.4. Recent Developments/ Strategic Initiatives
                        10.4.5. BD
                            10.4.5.1. Participant’s Overview
                            10.4.5.2. Financial Performance
                            10.4.5.3. Product Benchmarking
                            10.4.5.4. Recent Developments/ Strategic Initiatives
                        10.4.6. QIAGEN
                            10.4.6.1. Participant’s Overview
                            10.4.6.2. Financial Performance
                            10.4.6.3. Product Benchmarking
                            10.4.6.4. Recent Developments/ Strategic Initiatives
                        10.4.7. QuidelOrtho Corporation
                            10.4.7.1. Participant’s Overview
                            10.4.7.2. Financial Performance
                            10.4.7.3. Product Benchmarking
                            10.4.7.4. Recent Developments/ Strategic Initiatives
                        10.4.8. F. Hoffmann-La Roche
                            10.4.8.1. Participant’s Overview
                            10.4.8.2. Financial Performance
                            10.4.8.3. Product Benchmarking
                            10.4.8.4. Recent Developments/ Strategic Initiatives
                        10.4.9. DH Life Sciences, LLC.
                            10.4.9.1. Participant’s Overview
                            10.4.9.2. Financial Performance
                            10.4.9.3. Product Benchmarking
                            10.4.9.4. Recent Developments/ Strategic Initiatives
                        10.4.10. Quest Diagnostics
                            10.4.10.1. Participant’s Overview
                            10.4.10.2. Financial Performance
                            10.4.10.3. Product Benchmarking
                            10.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. lateral flow assay market, by region, 2018 - 2030 (USD Million)
Table 3 U.S. lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 5 U.S. lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 8 Europe lateral flow assay market, by country, 2018 - 2030 (USD Million)
Table 9 Europe lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 10 Europe lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 11 Europe lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 12 Europe lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 13 Europe lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 15 UK lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 16 UK lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 17 UK lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 18 UK lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 20 Germany lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 21 Germany lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 22 Germany lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 23 Germany lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 24 France lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 25 France lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 26 France lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 27 France lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 28 France lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 29 Italy lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 30 Italy lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 31 Italy lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 32 Italy lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 33 Italy lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 34 Spain lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 35 Spain lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 36 Spain lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 37 Spain lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 38 Spain lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 39 Denmark lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 40 Denmark lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 41 Denmark lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 42 Denmark lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 43 Denmark lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 44 Sweden lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 45 Sweden lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 46 Sweden lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 47 Sweden lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 48 Sweden lateral flow assay market, by end-use, 2018 - 2030 (USD Million)
Table 49 Norway lateral flow assay market, by product, 2018 - 2030 (USD Million)
Table 50 Norway lateral flow assay market, by application, 2018 - 2030 (USD Million)
Table 51 Norway lateral flow assay market, by technique, 2018 - 2030 (USD Million)
Table 52 Norway lateral flow assay market, by test type, 2018 - 2030 (USD Million)
Table 53 Norway lateral flow assay market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 US and Europe lateral flow assay market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 US and Europe lateral flow assay market: Product outlook key takeaways
Fig. 20 US and Europe lateral flow assay market: Product movement analysis
Fig. 21 Kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Lateral flow readers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Benchtop readers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Digital readers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 US and Europe lateral flow assay market: Application outlook key takeaways
Fig. 26 US and Europe lateral flow assay market: Application movement analysis
Fig. 27 Clinical testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Infectious disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Covid-19 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Mosquito borne disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Influenza testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Sexually transmitted infection testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 HIV testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 HPV testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Chlamydia testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Gonorrhea testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Syphilis testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Other STI testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Hepatitis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Tuberculosis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Other infectious diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Cardiac marker testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Troponin I and t testing
Fig. 44 CK-MB testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 BNP and NT-PROBNP testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Myoglobin testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 D-dimer testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Other cardiac marker tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Pregnancy & fertility testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Pregnancy testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Fertility testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Cholesterol testing/lipid profile market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Drugs of abuse testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Other clinical tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Veterinary diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Food safety & environment testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Drug development & quality testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 US and Europe lateral flow assay market: Technique outlook key takeaways
Fig. 59 US and Europe lateral flow assay market: Technique movement analysis
Fig. 60 Sandwich assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Competitive assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Multiplex detection assays market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 US and Europe Lateral Flow Assay market: Test Type outlook key takeaways
Fig. 64 US and Europe Lateral Flow Assay market: Test Type movement analysis
Fig. 65 Lateral flow immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Nucleic acid lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 US and Europe Lateral Flow Assay market: End-use outlook key takeaways
Fig. 68 US and Europe Lateral Flow Assay market: End-use movement analysis
Fig. 69 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Other End-use market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 75 Regional marketplace: Key takeaways
Fig. 76 US lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Europe US and Europe lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 UK lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Germany lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 France lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Spain lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Italy lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Denmark lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Sweden lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 Norway lateral flow assay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Market participant categorization
Fig. 96 US and Europe lateral flow assay market position analysis, 2024
Fig. 97 Strategic framework